What You Should Know:
- PathGroup, one of the largest providers of anatomic, clinical, digital, and molecular pathology services in the United States, is expanding its operations with Proscia's software platform (Concentriq® Dx) to further enhance the delivery of faster, higher quality results for millions of patients, helping to better inform treatment decisions.
- PathGroup currently supports more than 15,000 referring physicians and over 200 hospital
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Why Clinical Data Research Needs a Makeover in 2023
Clinical research is only as good and thorough as the data that’s available — and we need to do a better job of making that data accessible for researchers.
Unfortunately, the majority of clinical data is based on the same clinical sites and makes conclusions off a limited range of data points. Clinical trials often exclude minorities, rare disease subtypes and other underrepresented populations.
Changing the way we gather and share clinical data isn’t easy. Hospitals, biobanks and
Read More
Tempus, Pfizer Partner to Advance Oncology Therapeutic Development
What You Should Know:
- Today, the AI-powered genetic testing and precision medicine company Tempus announced that it has signed a significant strategic agreement with Pfizer to more precisely gather insights that will inform novel drug discovery and development in oncology.
- Through this collaboration, Pfizer has access to Tempus’ AI-enabled platform and its library of de-identified, multimodal data to uncover insights that will power therapeutic development in oncology.
-
Read More
Stratasys, Ricoh Partner to Provide On-Demand 3D-Printed Anatomic Models for Hospitals and Clinics
What You Should Know:
- Stratasys Ltd. today announced they have signed another agreement with RICOH USA to provide on-demand 3D-printed anatomic models for clinical settings.
- The demand for additive manufacturing within the healthcare industry is continuously growing, and according to Grandview Research, the global healthcare additive manufacturing market size was valued at USD 1.6 billion in 2021 and is expected to expand at a compound annual growth rate of 22.6% from 2022 to 2030.
Read More
Consumers Prefer Telehealth to In-Person Visits While Traveling
What You Should Know:
- New KeyCare survey finds nearly 7 in 10 (68%) of consumers who needed minor but urgent medical services while traveling in the prior year received care via telehealth visits with their regular physicians or affiliated members of their physicians’ care teams, outpacing all other care-delivery options.
- Results are based on a survey of 400 consumers who have previously scheduled and
Read More
Portfolia Invests in Xandar Kardian for Health Monitoring
What You Should Know:
- Portfolia, the world’s most powerful community of women investors, has officially announced a significant investment in Xandar Kardian from the firm’s Active Aging I and Active Aging II funds. Portfolia’s investment represents a core contribution to Xandar Kardian’s $10 million Series A Funding round.
- Portfolia sees Xandar Kardian’s impact extends well beyond the traditional hospital room, with impressive potential growth opportunities into a wider
Read More
Healthy.io & Reset Kidney Health Partner on Comprehensive Virtual Kidney Care
What You Should Know:
- Healthy.io, the global leader in transforming the smartphone camera into a medical device, and Reset Kidney Health, a hybrid care platform that offers gold-standard multidisciplinary care to patients with kidney disease, have announced a partnership that will give patients the option to utilize at-home, smartphone-powered kidney testing.
- As part of the partnership, Reset will provide eligible patients with Healthy.io's Minuteful Kidney™ test to complete at
Read More
What Impact Could AI Have On Genetic Testing?
The sequencing and analysis of human DNA have advanced significantly since the initial draft of a human genome that was published as part of the Human Genome Project. With DNA sequencing becoming increasingly cost-effective, the market for genetic testing is growing at an accelerating rate – the market for Next Generation Sequencing (NGS) services has an estimated annual growth of 18.3% from 2022 to 2030. AI presents a range of possibilities for this rapidly growing field, and in this article,
Read More
ObvioHealth Launches Digital Therapeutics API for Clinical Trials
What You Should Know:
- ObvioHealth launches proprietary application programming interface (API) tailored specifically for digital therapeutics (DTx) clinical trials.
- ObvioHealth’s API ensures tight integration between the digital therapeutic and the ObvioGo platform, providing sponsors with accurate data to correlate efficacy with adherence to the DTx. In addition, ObvioGo’s integration reduces participant task duplication because—in most cases—outcomes can be passively captured
Read More
Eko Launches Cardiac Disease Detection Platform, SENSORA
What You Should Know:
- Eko, a digital health company applying artificial intelligence (AI) in the fight against heart and lung disease launches the SENSORA™ Cardiac Disease Detection Platform.
- SENSORA™ currently features AI that objectively identifies structural murmurs, a sign of valvular heart disease, and Care Pathway Analytics software that provides downstream visibility and metrics of the patient journey through the healthcare system.
Eko SENSORA Cardiac Disease Detection
Read More
